Apolipoprotein E (ApoE) genotype is a powerful genetic modifier of Alzheimer's disease (AD). The ApoE4 isoform significantly reduces the mean age-of-onset of dementia through unknown mechanisms. Here, we show that ApoE4 selectively impairs synaptic plasticity and NMDA receptor phosphorylation by Reelin, a regulator of brain development and modulator of synaptic strength. ApoE4 reduces neuronal surface expression of Apoer2, a dual function receptor for ApoE and for Reelin, as well as NMDA and AMPA receptors by sequestration in intracellular compartments, thereby critically reducing the ability of Reelin to enhance synaptic glutamate receptor activity. As a result, the ability of Reelin to prevent LTP suppression by extracts from AD-afflicted human brains in hippocampal slices from knockin mice expressing the human ApoE4 isoform is severely impaired. These findings show an isoform-specific role of ApoE in the localization and intracellular trafficking of lipoprotein and glutamate receptors and thereby reveal an alternative mechanism by which ApoE4 may accelerate onset of dementia and neuronal degeneration by differentially impairing the maintenance of synaptic stability.
Apolipoprotein E (ApoE) genotype is a powerful genetic modifier of Alzheimer's disease (AD). The ApoE4 isoform significantly reduces the mean age-of-onset of dementia through unknown mechanisms. Here, we show that ApoE4 selectively impairs synaptic plasticity and NMDA receptor phosphorylation by Reelin, a regulator of brain development and modulator of synaptic strength. ApoE4 reduces neuronal surface expression of Apoer2, a dual function receptor for ApoE and for Reelin, as well as NMDA and AMPA receptors by sequestration in intracellular compartments, thereby critically reducing the ability of Reelin to enhance synaptic glutamate receptor activity. As a result, the ability of Reelin to prevent LTP suppression by extracts from AD-afflicted human brains in hippocampal slices from knockin mice expressing the human ApoE4 isoform is severely impaired. These findings show an isoform-specific role of ApoE in the localization and intracellular trafficking of lipoprotein and glutamate receptors and thereby reveal an alternative mechanism by which ApoE4 may accelerate onset of dementia and neuronal degeneration by differentially impairing the maintenance of synaptic stability.
Alzheimer's disease | lipoprotein receptor | neurodegeneration | NMDA receptor | Reelin A poE is a lipid transport protein that participates in the regulation of plasma cholesterol, the transport of dietary lipids (1) , and protection from atherosclerosis through ApoE receptormediated modulation of proliferative signals in smooth muscle cells (2) . ApoE is encoded by a single gene and exists in three isoforms (E2, E3, and E4) in the human population, which differ from each other by one or two amino acid substitutions at residues 112 and 158, respectively. The majority of the human population is homozygous for ApoE3 (1) . ApoE4 is present in ≈16% of the general population and is associated with a significantly earlier average age of onset of dementia, whereas the rare ApoE2 form is protective (3) . Differential effects of ApoE isoforms on amyloid-β clearance and the stability of the cytoskeleton have been reported (4) , but none of these mechanisms alone can fully explain the molecular basis by which ApoE4 significantly increases Alzheimer's disease (AD) risk.
ApoE receptors are abundantly expressed on neurons in the CNS. As endocytic receptors, they facilitate the transport of synaptogenic cholesterol (5) from astrocytes to neurons, but they also serve as classic signaling receptors for Reelin (6, 7), a ligand that regulates neuronal migration during embryonic development, as well as neurotransmission in the adult brain (8) . Reelin activates Src family non-receptor tyrosine kinases (SFKs) through clustering of postsynaptic ApoE receptor-2 (Apoer2) and very-low-density lipoprotein receptor (Vldlr) (8, 9) . SFKs subsequently phosphorylate NMDA receptor GluN2 subunits in a highly regulated manner that requires an alternatively spliced sequence motif in the cytoplasmic domain of Apoer2 (10) . Reelin thereby potently enhances NMDA receptor activity and increases long-term potentiation (LTP) (reviewed in ref. 8) . By contrast, amyloid-β peptide (Aβ) induces NMDA receptor-dependent synaptic suppression (11) by decreasing GluN2 tyrosine phosphorylation and increasing endocytosis of the NMDA receptor (12) . Reelin and ApoE receptors thus function together to reverse this NMDA receptordependent synaptic suppression by doing the opposite-i.e., increasing GluN2 tyrosine phosphorylation (8, 10) and thereby maintaining active NMDA receptors at the neuronal surface (13) .
The single amino acid by which ApoE4 differs from ApoE3 radically alters its intracellular trafficking properties. Whereas ApoE3 readily retroendocytoses, ApoE4 remains trapped in endosomes for extended periods of time (14) , raising the possibility that neuronal ApoE receptors could also remain sequestered along with ApoE in intracellular compartments in which they are unable to signal to glutamate receptors. Here, we show that ApoE4 preferentially depletes Apoer2, as well as NMDA and AMPA receptors, from the neuronal surface after ligand-induced endocytosis by Reelin. This reduction in signaling competent Apoer2 and surface glutamate receptors is accompanied by a sustained, reduced ability of Reelin to stimulate NMDA receptor-mediated Ca 2+ influx into cultured neurons. Hippocampal slices from knockin mice expressing the human ApoE4 isoform respond poorly to Reelin and fail to enhance LTP. Moreover, Reelin can effectively reverse the LTP suppression induced by oligomeric Aβ-containing brain extracts from patients afflicted with AD (13); this is severely impaired in ApoE4 knockin mice. These data show that ApoE4 selectively impairs glutamatergic neurotransmission by reducing ApoE, NMDA, and AMPA receptor functions, thereby facilitating the synaptic suppression mediated by β-amyloid.
Results
We first tested whether the recycling properties of the different ApoE isoforms in primary embryonic cortical neurons from wildtype mice match those reported previously (14) . Neurons were incubated for 15 min at 37°C with identical (3 μg/mL) concentrations of naturally secreted ApoE2, -E3, or -E4 lipoproteins resembling the small high-density lipoprotein (HDL)-like particles that are generated by astrocytes in the intact brain (15) . Surface-bound ApoE was then removed by suramin wash, and cells were chased for an additional 30-120 min. ApoE was then immunoprecipitated from the chase supernatant and cell lysates, and analyzed by immunoblotting (Fig. 1A) . Primary mouse cortical neurons do not produce any detectable amounts of ApoE (lanes 1, 5, and 9). Consistent with the earlier reports, ApoE4 release into the culture medium (lanes 4, 8, and 12) during the chase period was markedly delayed compared with ApoE2 (lanes 2, 6, and 10) and ApoE3 (lanes 3, 7, and 11). Substantially more ApoE4 was retained in intracellular compartments at all time points, confirming that impaired recycling of ApoE4 also occurs in primary neurons.
We next used cell-surface biotinylation to test whether this increased sequestration of ApoE4 in intracellular compartments might result in an altered expression of Apoer2 at the plasma membrane (Fig. 1B) . Whereas ApoE2 (lane 2) and ApoE3 (lane 3) did not reduce surface expression of Apoer2 compared with the control (lane 1), ApoE4 significantly decreased surface expression of this "dual function" Reelin and ApoE receptor (lane 4), suggesting that Apoer2 availability, and thus function, at the cell surface might be impaired.
Because Reelin induces endocytosis of its receptors, we tested whether activation of Reelin signaling in the presence of ApoE would further decrease cell-surface expression of Apoer2. All ApoE isoforms (Fig. 1C , lanes 2-4) significantly decreased sur- Fig. 1 . ApoE4 suppresses neuronal surface expression of Apoer2. (A) Primary neurons were incubated with ApoE at 3 μg/mL for 30 min at 37°C. Surface-bound ApoE was released by washing the cells with suramin, and neurons were incubated with fresh Neurobasal medium for an additional 30 min, 1 h, or 2 h at 37°C. Media and neuronal lysates were analyzed by immunoblotting for human ApoE or β-actin (loading control). (B) Apoer2 expressed at the plasma membrane of neurons treated with the indicated ApoE isoforms for 15 min at 3 μg/mL was labeled with membraneimpermeable biotin. Cell lysates were incubated with neutravidin beads, and bound proteins were analyzed by immunoblotting with anti-Apoer2 antibody (Upper) to visualize surface Apoer2. Total cellular Apoer2 levels were determined by loading 10% of the total cell lysates (Lower). Relative surface Apoer2 levels were determined by normalizing biotinylated Apoer2 levels to the corresponding total Apoer2 levels. Averaged surface Apoer2 levels, which were standardized to control, from four independent experiments are shown. *P < 0.05; **P < 0.01, compared with control, unpaired t test. (C) Neurons were incubated with 3 μg/mL ApoE together with Reelin (2 μg/mL, to stimulate ligand-induced receptor endocytosis) for 2 h at 37°C. Cell lysates were incubated with neutravidin beads, and bound proteins were analyzed by immunoblotting with anti-Apoer2 antibody (Top) to visualize surface Apoer2. Total cell lysates were analyzed directly by immunoblotting for Apoer2 (Middle) or β-actin (loading control, Bottom). Average relative surface levels of Apoer2 were quantitated as described in B. Asterisks above individual columns indicate significant difference compared with control. Asterisks on brackets indicates significant difference between treatments. *P < 0.05; **P < 0.01; ***P < 0.001. Response delay due to wash-in of glutamate is ≈20 s. (E) Averaged ΔR (the maximal difference in 340/380 ratio induced by glutamate) recorded from primary neurons subjected to the indicated treatments in the absence or presence of ∼5 nM Reelin and 0, 1, or 3 μg/mL ApoE2, -E3, or -E4 (n = 20-50). Asterisks above individual columns indicate significance (P < 0.001) compared with control neurons receiving no treatment (ApoE nor Reelin). Asterisks on brackets indicate significant difference (P < 0.001) between treatments; unpaired t test. (F) Native but not boiled (CR50*) function blocking CR50 antibody prevents Reelin-dependent Ca 2+ influx. (G) ApoE4 diminishes Reelin-induced GluN2A and B tyrosine phosphorylation (pGluN2 compared with total cellular GluN2). β-actin, loading control. (H and I) ApoE4 reduces GluA1, GluA2/3, and GluN2B cell-surface levels in acutely Reelin stimulated primary neurons. GluN2A surface levels were too low for reliable detection.
face expression of Apoer2 upon Reelin stimulation compared with control (lane 1). ApoE3 was marginally, but not significantly, more effective than ApoE2, whereas ApoE4 led to a dramatic and statistically highly significant reduction of Apoer2 at the neuronal cell surface. These findings suggested that the activation of NMDA receptors by Reelin, which depends on Apoer2 (10), might be impaired in the presence of ApoE, particularly ApoE4.
We therefore tested whether preincubation with the same ApoE isoforms would also selectively impair Reelin-dependent Ca 2+ influx into primary cortical neurons evoked by stimulation of NMDA receptors with glutamate (16) . In the absence of ApoE preincubation, Reelin robustly increased intracellular, NMDA receptor-dependent Ca 2+ levels ( Fig. 2A) . ApoE induced a quantitative reduction in NMDA receptor-dependent Ca 2+ influx that was isoform-dependent ( Fig. 2 B-D) and dose-dependent (Fig.  2E ). ApoE2 had almost no effect at 1 μg/mL, but at 3 μg/mL it reduced the maximal response (ΔR) to ≈50% of the (no ApoE) control. ApoE3 partially reduced NMDA receptor activity at 1 and 3 μg/mL, whereas ApoE4 substantially decreased intracellular Ca 2+ levels already at 1 μg/mL and almost completely abolished NMDA receptor-dependent Ca 2+ influx at 3 μg/mL. Glutamateinduced Ca 2+ influx was abolished by the Reelin function blocking CR50 antibody (Fig. 2F) . The powerful effect of ApoE4 on NMDA receptor function correlated with the almost complete suppression of Reelin-dependent GluN2 subunit tyrosine phosphorylation (Fig. 2G ) and a reduction of not only NMDA but also AMPA receptor subunits at the cell surface ( Fig. 2 H and I) , consistent with the absence of an isoform effect on AMPA/NMDA ratios ( Fig. S1 and Tables S1-S4).
Synaptic NMDA receptor activation is neuroprotective (17) by triggering the phosphorylation of the transcription factor CREB. Reelin greatly increases CREB phosphorylation in response to glutamate (16) . Because synaptic dysfunction precedes neuronal death in AD, we decided to investigate whether ApoE4 would also selectively impair nuclear phospho-CREB (pCREB) levels. Cultured cortical neurons were treated as described in Fig. 2 , fixed, and stained with a p Ser133 CREB-specific antibody. No nuclear pCREB staining was detected in the absence of Reelin (Fig. 3A) . By contrast, robust nuclear staining was detected in the presence of Reelin in neurons treated with no ApoE, ApoE2, or ApoE3, but not in neurons exposed to ApoE4. The intensity of nuclear fluorescence was plotted against the number of neuronal nuclei (Fig. 3B) . Treatment with ApoE4 essentially abolished nuclear pCREB accumulation.
To determine whether ApoE4 impairs the activity enhancing effect of Reelin on glutamate receptor-dependent synaptic functions (8, 10) to a similar extent in vivo, we measured the ability of Reelin to increase θ-burst-induced LTP in the CA1 region in hippocampal slices from homozygous ApoE2, ApoE3, and ApoE4 knockin mice (18) , where the endogenous mouse ApoE is replaced with the human ApoE sequence. No exogenous ApoE was added in these experiments. Hippocampal slices from mice expressing exclusively the human ApoE2 (Fig. 4A) or ApoE3 (Fig. 4B) isoforms had normal baseline LTP, which was enhanced by Reelin to a similar extent as observed in slices from wild type mice which express murine ApoE (10) . By contrast, ApoE4 expressing slices completely failed to increase LTP following Reelin stimulation (Fig. 4 C and D) . Paired pulse facilitation was not different between the different ApoE knockin strains at any interpulse interval (Fig. 4E) . Input-output ratios were not different between genotypes (Fig. 4F) .
Activation of Reelin signaling at the synapse can prevent β-amyloid-induced LTP suppression (13) . To test ability of Reelin to maintain normal hippocampal LTP in the presence of naturally occurring oligomeric Aβ, we perfused hippocampal slices from the different ApoE knockin mice with ACSF containing either brain extract from a human non-AD case (Fig. 5, Control, squares) , extract isolated from a confirmed human AD case (AD, circles) or AD extract and Reelin (Reelin + AD, triangles). The AD brain extract, but not the control extract, contained the active oligomeric Aβ species, which potently suppresses LTP and NMDA receptor activity in the mouse hippocampus. The effect of AD brain extract on LTP suppression and the ability of Reelin to prevent this suppression (13) varied greatly, depending on which ApoE isoform was endogenously expressed in the slice. Although AD extract alone had little effect on baseline LTP in the presence of ApoE2 (Fig. 5A) , it potently suppressed LTP in ApoE3 (Fig.  5B) and ApoE4 (Fig. 5C) slices. By contrast, Reelin was able to enhance LTP significantly above baseline even in the presence of AD extract in the ApoE2 slices (Fig. 5A) . In ApoE3-expressing slices, Reelin could completely prevent LTP suppression induced by AD brain extract (Fig. 5B) , whereas Reelin was almost ineffective in the presence of endogenous ApoE4 (Fig. 5C) . Thus, 
circles). (B) In
ApoE3 knockin slices, incubation with AD brain extract (20 μL/mL perfusate, circles) caused a significant reduction in LTP (102.99 ± 6.09%, n = 10) compared with control extract (20-50 μL/mL perfusate, squares, 134.65 ± 8.25%, n = 9). Reelin coapplication together with AD extract (triangles) restored LTP (139.00 ± 8.39%, n = 15) back to control levels. (C) In ApoE4 knockin slices incubation with AD brain extract (20 μL/mL perfusate, circles) caused a significant reduction in LTP (120.84 ± 9.25%, n = 12) compared with control extract (20-50 μL/mL perfusate, squares, 139.33 ±6.33%, n = 14). Reelin coapplication failed to restore LTP (124.78% ± 7.44, n = 17) in the presence of AD brain extract (triangles) in these animals. (Bottom) One-way ANOVA for repeated measures followed by Bonferroni posttest of normalized fEPSP slope (20-80%) values. Baseline and treatment data (0-60 min) were analyzed and compared with each other at each time point, pooled, and expressed as the mean ± SEM. Mice were age-matched and recordings from the control and treated slices were done on the same day. An asterisk denotes significance. (A Bottom) Control compared with AD extract, P > 0.05; AD extract compared with Reelin + AD extract, P > 0.05; control extract compared with AD extract + Reelin, P < 0.05. (B Bottom) Control compared with AD extract, P < 0.05; AD extract compared with Reelin + AD extract, P < 0.05; control extract compared with AD extract + Reelin, P > 0.05. (C Bottom) Control compared with AD extract, P < 0.05; AD extract compared with Reelin + AD extract, P > 0.05; control extract compared with AD extract + Reelin, P < 0.05.
ApoE4, but not ApoE2 or ApoE3, significantly impair the ability of synaptic ApoE receptor signaling to counterbalance the synapse depressing effect of Aβ oligomers.
Discussion
ApoE4 significantly reduces the surface expression of Apoer2 in primary cultured neurons by sequestering the receptor in intracellular recycling compartments. This explains how ApoE isoforms differentially antagonize the activation of NMDA receptor-dependent Ca 2+ influx by ApoE receptors in a dose-dependent manner. Consequently, in ApoE4 knockin mice, the ability of Reelin to enhance LTP and thereby increase synaptic plasticity in vivo and prevent Aβ-induced LTP suppression is almost completely abolished.
The cellular mechanisms by which ApoE isoforms differentially affect the age-of-onset of the most common late-onset form of AD have remained unclear. Aβ peptides bind to ApoE and different ApoE isoforms have been reported to differentially affect the rate of clearance of Aβ by cells and across the bloodbrain barrier (19) . ApoE also affects Aβ fibrillogenesis and plaque formation (20) . Aβ oligomers potently suppress synaptic functions and impair synaptic plasticity (reviewed in ref. 21 ), and we have recently shown that Reelin signaling through Apoer2 can prevent the Aβ oligomer-induced inhibition of NMDA receptors at the synapse (13) .
In the CNS, ApoE is produced by the glia (reviewed in ref. 4 ), while multifunctional ApoE receptors are abundantly expressed on the neuronal cell surface where they perform "double duty," mediating lipoprotein uptake as well as signal transduction (8, 16) . One of these ApoE receptors, Apoer2, and its ligand Reelin are powerful modulators of NMDA receptor functions in vitro and in vivo (8, 10, 16) . Taken together, these findings suggest a possible mechanism by which ApoE isoforms could differentially accelerate synapse dysfunction and AD dementia by interfering with ApoE receptor-dependent neuromodulation (8) . Two potential mechanisms by which ApoE might interfere with Reelin signaling are (i) through direct inhibition of binding or (ii) by altering subcellular receptor trafficking. Ligand binding interference is an attractive mechanism that could explain the relative protective effect of ApoE2 over ApoE3. Receptor binding affinity of ApoE2 is reduced by ≈2 orders of magnitude (1) . It can, however, not easily explain the powerful disease promoting effect of ApoE4 over ApoE3, because these isoforms bind to receptors with equal affinity (1) .
In earlier studies, Heeren et al. (14) have investigated the trafficking properties of ApoE3 and ApoE4 and found a significant accumulation of ApoE4 in intracellular compartments following endocytosis. Taken together, these observations raised the possibility that ApoE4 might also retard ApoE receptor recycling, thereby effectively sequestering a fraction of the receptors inside the cell where they would be unable to signal.
Our findings support such a model (Fig. 6 ). Exogenously added, naturally secreted ApoE4, but not ApoE2 and ApoE3 lipoproteins significantly decreased neuronal cell surface expression of Apoer2 (Fig. 1) and NMDA receptor mediated Ca 2+ entry (Fig. 2) . Less effective competition by ApoE2 might also manifest itself in this way through reduced interference and higher Ca 2+ flux. This relative effect of the ApoE isoforms on Reelin and glutamate evoked Ca 2+ influx intriguingly parallels the order of their relative contribution to AD age-of-onset (3). Moreover, these in vitro findings also bear direct relevance to the function of the intact CNS, where endogenously produced ApoE4, but not ApoE3 or ApoE2 severely impaired the ability of Reelin to enhance hippocampal LTP (Fig. 4) and prevent the synaptic suppression induced by AD brain extract in ApoE4 slices (Fig. 5C ).
ApoE levels in total brain extracts average ≈5 μg/mL (22) . The ApoE concentrations we have used in this study lie well within this physiological range. Reelin signaling through ApoE receptors thus appears to be one of several physiological components of a kinase network that controls and integrates glutamate receptor-dependent neuronal activity, which is differentially modulated by the effect of ApoE isoforms on ApoE and glutamate receptor trafficking.
From these findings and those of several other groups emerges a picture in which the trafficking of the amyloid precursor protein (APP) and ApoE receptors, ApoE receptor and APP expression, APP processing and Aβ generation, and modulation of synaptic transmission by ApoE receptors and Aβ (reviewed in refs. 8 and 21) are cornerstones of an integrated signaling network that is critical for optimizing synaptic responsiveness. Dis- Fig. 6 . Effect of ApoE isoforms on ApoE receptor signaling at the synapse. Apoer2 induces NMDAR tyrosine phosphorylation by activating SFKs in response to Reelin in the postsynaptic neuron (8, 10, 16) . Astrocyte-derived ApoE3 (green ovals) or ApoE4 (gray ovals) bind to Apoer2 and are constitutively but slowly internalized. Apoer2 undergoes accelerated endocytosis in response to Reelin signaling ( Fig. 1) (25) . ApoE4 sequesters Apoer2 in intracellular compartments thereby reducing the ability of the postsynaptic neuron to phosphorylate (activate) NMDA receptors in response to Reelin (shown on the right), whereas ApoE2 or ApoE3 efficiently recycle back to the cell surface and thus deplete surface Apoer2 levels to a lesser extent (illustrated on the left for ApoE3). Aβ oligomers interfere with NMDAR tyrosine phosphorylation by activating tyrosine phosphatases (13, 24) . ruption of this highly interconnected and ordered process may result in a self-reinforcing, progressive synaptic network dysfunction (23) that might accelerate synapse destabilization and neuronal loss. We propose a mechanism (Fig. 6 ) in which an ApoE isoform-selective impairment of ApoE receptor signaling, through reduced counter regulation of Aβ induced synaptic depression, ensues a concomitant decrease in synaptic responsiveness. These findings provide a mechanistic rationale that may explain, at least in part, the differential effects of ApoE isoforms on memory, learning, and neuronal survival.
Experimental Procedures
Please refer to SI Experimental Procedures for a more extensive description of the experimental procedures used.
ApoE Recombinant Protein Preparation. HEK 293 cells (CRL-1573; ATCC) were transfected using FuGENE 6 reagent with pcDNA3.1 zeo(+), pcDNA3.1 zeo(+) human ApoE2, pcDNA3.1 zeo(+) human ApoE3, or pcDNA3.1 zeo(+) human ApoE4. ApoE lipoproteins were naturally secreted from stably transfected clones at concentrations of ≈10 μg/mL protein in serum-free Neurobasal media.
ApoE Recycling. Primary cortical neurons were cultured for 12-13 d as described in ref. 16 , and ApoE trafficking and recycling was determined as described in SI Experimental Procedures.
Surface Biotinylation. Surface expression of ApoE receptors was monitored by surface biotinylation and immunoprecipitation as described in detail in SI Experimental Procedures.
Calcium Imaging. Reelin-and NMDA receptor-dependent Ca 2+ influx was determined as described in ref. 16 and in SI Experimental Procedures.
Immunocytochemistry. Primary neurons were treated and stimulated as described in Calcium Imaging (just above and in SI Experimental Procedures). Neurons were fixed and processed with a polyclonal antibody directed against Ser-133 phosphorylated CREB as described in ref. 16 .
Hippocampal Slice Preparation and Field Recording. LTP was determined in 2-to 3-month-old mice of the indicated genotype as described in ref. 13 and in SI Experimental Procedures.
Preparation of Human Brain Extracts and Prevention of LTP Suppression by
Reelin. Human brain extracts from control and histopathologically confirmed AD brain were prepared and their effect on hippocampal LTP was determined as described in ref. 13 and in SI Experimental Procedures.
